Cargando…

Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease

Overdiagnosis and overtreatment of low-grade prostate cancer (PCa) reflect poor quality of care and prompted changes to guidelines over the past decade. We used the National Cancer Database to characterize Gleason Grade Group (GG)1 PCa diagnosis trends and assess facility-level treatment variability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borregales, Leonardo D, Tzeng, Michael, Ramaswamy, Ashwin, Gu, Xiangmei, Davuluri, Meenakshi, Nagar, Himanshu, Hu, Jim C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133398/ https://www.ncbi.nlm.nih.gov/pubmed/36840651 http://dx.doi.org/10.1093/jncics/pkad018

Ejemplares similares

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Intraductal Carcinoma of the Prostate: To Grade or Not to Grade
por: Surintrspanont, Jerasit, et al.
Publicado: (2023)

Graded rings and graded Grothendieck groups
por: Hazrat, Roozbeh
Publicado: (2016)

Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US
por: Agrawal, Vishesh, et al.
Publicado: (2020)

Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings
por: Beckmann, Kerri, et al.
Publicado: (2019)

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy
por: Agrawal, Vishesh, et al.
Publicado: (2022)

Prostatic Adenocarcinoma: A Grading from Gleason to the New Grade-Group System: A Historical and Critical Review
por: Barakzai, Muhammad Abrar
Publicado: (2019)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms
por: Leoncini, Emanuele, et al.
Publicado: (2017)

Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs
por: Eoh, Kyung Jin, et al.
Publicado: (2021)

Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer
por: Cook, Kiri, et al.
Publicado: (2020)

Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis
por: Yamada, Yasutaka, et al.
Publicado: (2017)

Depatux-M and temozolomide in advanced high-grade glioma
por: Hirsch, Sophie, et al.
Publicado: (2020)

The performance of the new prognostic grade and stage groups in conservatively treated prostate cancer
por: Chen, Cheng, et al.
Publicado: (2018)

Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings
por: Beckmann, K. R., et al.
Publicado: (2017)

How Much Reliable Is the Current Belief on Grade Group 1 Prostate Cancer?
por: Chung, Mun Su, et al.
Publicado: (2021)

High-Grade Prostatic Intraepithelial Neoplasia
por: Klink, Joseph C, et al.
Publicado: (2012)

New prostate cancer grade group system correlates with prostate cancer death in addition to biochemical recurrence
por: Epstein, Jonathan I
Publicado: (2016)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
por: Tzeng, Michael, et al.
Publicado: (2021)

A Case of Low-Grade Fibromyxoid Sarcoma Arising in the Finger
por: Han, Byeol, et al.
Publicado: (2018)

Low-grade prostate cancer diverges early from high grade and metastatic disease
por: VanderWeele, David J, et al.
Publicado: (2014)

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading
por: Egevad, Lars, et al.
Publicado: (2020)

Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma
por: Tzelepi, Vasiliki, et al.
Publicado: (2021)

Racial Variation in Membranous Urethral Length and Postprostatectomy Urinary Function
por: Basourakos, Spyridon P., et al.
Publicado: (2021)

Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
por: Offermann, Anne, et al.
Publicado: (2017)

Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
por: Lucas, Marit, et al.
Publicado: (2019)

Expression and Clinical Significance of HKII and HIF-1α in Grade Groups of Prostate Cancer
por: Sun, Xueqi, et al.
Publicado: (2021)

Discriminatory Gleason grade group signatures of prostate cancer: An application of machine learning methods
por: Mokoatle, Mpho, et al.
Publicado: (2022)

Active surveillance should be considered for select men with Grade Group 2 prostate cancer
por: Pekala, Kelly R., et al.
Publicado: (2023)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

Property ($T$) for groups graded by root systems
por: Ershov, Mikhail, et al.
Publicado: (2017)

No evidence for PALB2 methylation in high-grade serous ovarian cancer
por: Mikeska, Thomas, et al.
Publicado: (2013)

The CSC graded Lie group as a quantum group
por: Tripathy, K C, et al.
Publicado: (1993)

Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
por: Fairey, Adrian, et al.
Publicado: (2023)

Grading of prostate cancer: a work in progress
por: Kweldam, C F, et al.
Publicado: (2018)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001–2007
por: Li, Jun, et al.
Publicado: (2012)

External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
por: Bengió, Rubén G., et al.
Publicado: (2020)

Are we ready to include invasive cribriform and intraductal carcinoma into the prostate cancer grade grouping system?
por: Xiao, Guang-Qian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pm4n5tqgsuvjlcb1khbhji3isj